Definitive Healthcare Corp. (DH): Price and Financial Metrics
DH Price/Volume Stats
| Current price | $7.27 | 52-week high | $12.45 |
| Prev. close | $7.33 | 52-week low | $5.53 |
| Day low | $7.24 | Volume | 733,074 |
| Day high | $7.57 | Avg. volume | 583,443 |
| 50-day MA | $8.29 | Dividend yield | N/A |
| 200-day MA | $8.76 | Market Cap | 856.33M |
DH Stock Price Chart Interactive Chart >
Definitive Healthcare Corp. (DH) Company Bio
Definitive Healthcare Corp., through its subsidiaries, provides healthcare commercial intelligence. It offers information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. The company's platform currently offers 13 intelligence modules. It serves life sciences companies, healthcare information technology companies, healthcare providers, and other diversified companies. The company was founded in 2011 and is based in Framingham, Massachusetts.
Latest DH News From Around the Web
Below are the latest news stories about DEFINITIVE HEALTHCARE CORP that investors may wish to consider to help them evaluate DH as an investment opportunity.
Are Investors Undervaluing Definitive Healthcare Corp. (NASDAQ:DH) By 49%?Key Insights Definitive Healthcare's estimated fair value is US$17.36 based on 2 Stage Free Cash Flow to Equity... |
Should You Invest in Definitive Healthcare Corp. (DH)?Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The micro capitalization segment of the market proved the most challenging in the quarter with the Russell Micro Cap Index declining -7.93%. The Russell Micro Cap Growth Index fell further with a […] |
Definitive Healthcare Corp. (NASDAQ:DH) Q3 2023 Earnings Call TranscriptDefinitive Healthcare Corp. (NASDAQ:DH) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Welcome to the Definitive Healthcare Q3 2023 Earnings Call. Our host for today’s call is Robert Musslewhite. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. I would now like to turn the call […] |
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)FRAMINGHAM, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of Carrie Lazorchak as Definitive Healthcare’s new Chief Revenue Officer, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted Ms. Lazorchak an inducement award consisting of 385,695 time-based restricted stock units (“RSUs”) e |
Definitive Healthcare Corp (DH) Reports 14% YoY Revenue Growth in Q3 2023Despite a significant net loss, the company shows strong performance in adjusted EBITDA and net income |
DH Price Returns
| 1-mo | -4.47% |
| 3-mo | -21.49% |
| 6-mo | 18.99% |
| 1-year | -36.67% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -26.86% |
| 2023 | -9.55% |
| 2022 | -59.79% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...